Fibromyalgia patients who slept better and felt less anxious on medical cannabis also reported less pain
Over 12 months, fibromyalgia patients who started medical cannabis saw pain reductions, and those improvements were partly explained by concurrent improvements in sleep and negative mood.
Quick Facts
What This Study Found
Reductions in pain intensity among fibromyalgia patients using medical cannabis were partially mediated by concurrent improvements in sleep quality and reductions in anxiety and depression symptoms.
Key Numbers
323 fibromyalgia patients followed for 12 months. Pain reduction partially mediated by improvements in negative affect (anxiety and depression) and sleep quality.
How They Did This
12-month prospective cohort study of 323 fibromyalgia patients initiating medical cannabis. Assessments at baseline and multiple follow-ups measured pain intensity, sleep quality, anxiety, and depression. Mediation analysis tested whether sleep and mood changes explained pain improvements.
Why This Research Matters
Fibromyalgia pain is tightly linked to sleep and mood. Understanding that cannabis may reduce pain partly by improving these co-occurring symptoms could help clinicians set realistic expectations and optimize treatment approaches.
The Bigger Picture
Fibromyalgia is notoriously difficult to treat, and symptoms cluster together. If medical cannabis helps by addressing the symptom cluster rather than pain alone, it suggests a different therapeutic model than traditional single-target pain medications.
What This Study Doesn't Tell Us
No control group or randomization. Patients self-selected into medical cannabis use. Cannot separate cannabis effects from placebo, natural symptom fluctuation, or concurrent treatments. High attrition over 12 months is possible but not detailed.
Questions This Raises
- ?Would these mediation pathways hold in a randomized controlled trial?
- ?Which cannabis formulations or cannabinoid profiles are most effective for the sleep-mood-pain cluster in fibromyalgia?
Trust & Context
- Key Stat:
- 323 fibromyalgia patients followed for 12 months on medical cannabis
- Evidence Grade:
- Prospective cohort with reasonable sample size and 12-month follow-up. Lack of control group limits causal inference.
- Study Age:
- Published 2022.
- Original Title:
- Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.
- Published In:
- Arthritis care & research, 75(7), 1588-1594 (2023)
- Authors:
- Sotoodeh, Romina, Waldman, Lilach Eyal, Vigano, Antonio(4), Moride, Yola, Canac-Marquis, Michelle, Spilak, Tristan, Gamaoun, Rihab, Kalaba, Maja, Hachem, Yasmina, Beaulieu, Pierre, Desroches, Julie, Ware, Mark A, Perez, Jordi, Shir, Yoram, Fitzcharles, Mary-Ann, Martel, Marc O
- Database ID:
- RTHC-04953
Evidence Hierarchy
Frequently Asked Questions
Does cannabis help fibromyalgia pain?
In this 12-month observational study, fibromyalgia patients who started medical cannabis reported pain reductions. However, without a control group, it is impossible to know how much of the improvement was due to cannabis versus placebo effect, natural symptom variation, or other factors.
Why would sleep and mood improvements reduce pain?
Fibromyalgia involves central sensitization, where the nervous system amplifies pain signals. Poor sleep and elevated anxiety/depression worsen this sensitization. Improving sleep and mood may dial down the nervous system amplification, reducing the perceived intensity of pain.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-04953APA
Sotoodeh, Romina; Waldman, Lilach Eyal; Vigano, Antonio; Moride, Yola; Canac-Marquis, Michelle; Spilak, Tristan; Gamaoun, Rihab; Kalaba, Maja; Hachem, Yasmina; Beaulieu, Pierre; Desroches, Julie; Ware, Mark A; Perez, Jordi; Shir, Yoram; Fitzcharles, Mary-Ann; Martel, Marc O. (2023). Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.. Arthritis care & research, 75(7), 1588-1594. https://doi.org/10.1002/acr.24985
MLA
Sotoodeh, Romina, et al. "Predictors of Pain Reduction Among Fibromyalgia Patients Using Medical Cannabis: A Long-Term Prospective Cohort Study.." Arthritis care & research, 2023. https://doi.org/10.1002/acr.24985
RethinkTHC
RethinkTHC Research Database. "Predictors of Pain Reduction Among Fibromyalgia Patients Usi..." RTHC-04953. Retrieved from https://rethinkthc.com/research/sotoodeh-2023-predictors-of-pain-reduction
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.